Fenfluramine and 5-hydroxytryptamine?. Part 1: Is fenfluramine or norfenfluramine involved in the decrease of brain 5-hydroxytryptamine. 1975

J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt

Both fenfluramine and de-ethylated fenfluramine decrease the brain stores of 5-hydroxytryptamine (5-HT). As the fenfluramine metabolite is present in the brain of the rat after fenfluramine injection, it could be suggested that the depletion of brain 5-HT elicited by fenfluramine is mediated by its metabolite. Comparative studies on 5-HT lowering effects and drug brain levels, indicate a primary effect of fenfluramine, following by the rising involvement of the de-ethylated compound in the sustained effect.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D004027 Diencephalon The paired caudal parts of the PROSENCEPHALON from which the THALAMUS; HYPOTHALAMUS; EPITHALAMUS; and SUBTHALAMUS are derived. Interbrain,Interbrains
D005277 Fenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. Fintepla,Fenfluramine Hydrochloride,Fenfluramine Hydrochloride, (+-)-Isomer,Fenfluramine Hydrochloride, R-Isomer,Fenfluramine, (+-)-Isomer,Fenfluramine, R-Isomer,Isomeride,Pondimin,Fenfluramine Hydrochloride, R Isomer,Fenfluramine, R Isomer,Hydrochloride, Fenfluramine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D013687 Telencephalon The anterior subdivision of the embryonic PROSENCEPHALON or the corresponding part of the adult prosencephalon that includes the cerebrum and associated structures. Endbrain,Endbrains
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
March 1982, British journal of pharmacology,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
June 1971, The Journal of pharmacy and pharmacology,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
February 1998, The Journal of pharmacology and experimental therapeutics,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
September 2005, The Journal of pharmacology and experimental therapeutics,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
January 1986, Neurochemistry international,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
October 1994, European journal of pharmacology,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
May 2004, The Journal of pharmacology and experimental therapeutics,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
January 1976, European journal of pharmacology,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
September 1983, The Journal of pharmacy and pharmacology,
J Duhault, and C Malen, and M Boulanger, and C Voisin, and L Beregi, and H Schmitt
February 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!